Business development
We have over 20 years of experience in the pharmaceutical industry in Mexico and Latin America.
Our capabilities and exclusive focus on licensing innovative molecules position us as a pharmaceutical company with world-class standards and the best partner of choice to successfully market products in Latin America.
Business development
At Stendhal, we create shared value by establishing and developing long-term partnerships, strengthening our portfolio to meet the region's health needs.
We seize and develop market opportunities with a dynamic and flexible approach, making us a reliable strategic partner. We are present in Mexico, Colombia, Peru, Ecuador, Central America, and the Caribbean, and we have positioned ourselves as a benchmark in the launch of innovative pharmaceutical products in Latin America, ensuring regulatory compliance in each country in which we operate.
Our experience and distinguishing attributes
- Flexible solutions based on each partner's needs and regional context.
- Long-term strategic alliances with top-tier companies at a global level.
- Exclusivity in licensing innovative medications, offering the best treatments at a regional level.
- Robust experience in regulatory issues with an experienced and highly qualified team that bolsters the regulatory approval of innovative pharmaceutical products.
- High standards for Compliance with well-established compliance processes at a regional level.
- Implementation of best Pharmacovigilance practices, periodically audited by our partners.
- Extensive experience in Intellectual Property to safeguard and maximize the protection of patents of the products we market.
- A Medical Department recognized by opinion leaders and regional relationships that support the entire life cycle of products from registration to marketing.
Contact: BDStendhal@stendhalpharma.com
